Last reviewed · How we verify
Placebo (for KRG)
Placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, without active pharmacological ingredients.
Placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, without active pharmacological ingredients. Used for KRG (indication not specified; likely a clinical trial or institutional code).
At a glance
| Generic name | Placebo (for KRG) |
|---|---|
| Also known as | Placebo |
| Sponsor | Chuncheon Sacred Heart Hospital |
| Modality | Small molecule |
| Therapeutic area | Multiple (context-dependent; commonly Pain, Nausea, Fatigue) |
| Phase | FDA-approved |
Mechanism of action
Placebo works via psychological and neurobiological mechanisms including expectation, conditioning, and activation of endogenous pain-relief and healing pathways. The effect is particularly pronounced in conditions with subjective symptom components such as pain, nausea, and fatigue. While placebo has no direct molecular target, it can produce measurable physiological changes through mind-body interactions.
Approved indications
- KRG (indication not specified; likely a clinical trial or institutional code)
Common side effects
- Nocebo effects (adverse expectations)
- Minimal direct adverse events
Key clinical trials
- Effect of Red Ginseng Extract on Changes in Indicators of Immune Function in Vietnamese Healthy Volunteers (PHASE1)
- Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease (NA)
- Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study (PHASE4)
- Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation (PHASE2)
- Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis (PHASE4)
- Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension (PHASE2)
- Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for KRG) CI brief — competitive landscape report
- Placebo (for KRG) updates RSS · CI watch RSS
- Chuncheon Sacred Heart Hospital portfolio CI